MLM Company Herbalife Adds Indian Physician To Advisory Board

Herbalife Ltd. (NYSE:HLF) has expanded its Nutrition Advisory Board (NAB) with the addition of Anoop Misra, M.D. of India, an internationally recognized specialist on diabetes and metabolic disease. Anoop Misra was awarded Padma Shri (one of the highest national honors) by the President of India.

The Herbalife NAB is comprised of leading experts around the world in the fields of nutrition and health who educate and train Herbalife independent distributors on the principles of nutrition, physical activity and a healthy lifestyle. The board is chaired by David Heber, M.D., Ph.D., director of the Center for Human Nutrition at the University of California, Los Angeles (UCLA).

MLM Company Amway In Romania

Direct sales company Amway Marketing Romania, estimates a 20-30% turnover increase for this year, which would bring the company's business to around 37 million euros, with a business growth rate of half that seen in the last three years. Amway Marketing Romania, which sells cosmetic products, food additives, and household care products, has posted monthly sales of 3 to 4 million dollars (2.2 to 3 million euros), up 20-30% on the same period last year. "I don't think we will see a 50% increase in turnover this year, because we have already reached a size at which such a rate of growth is not possible any more.

MLM Company Herbalife Appoints New Chairman

Herbalife Ltd., which markets nutritional supplements, said late Wednesday it named Chief Executive Michael O. Johnson chairman.

Johnson succeeds Peter Castleman, who resigned to focus on his other business activities, the company said.

MLM Newsletter "MarketWave Alert" - Issue #79

Latest issue of Len Clements' "MarketWave Alert" continues with the USANA versus FDI saga...

For any of you following Barry Minkow's attack on Usana (which is actually an attack on MLM backed by the Pyramid Scheme Alert organization), check out Dr. Jon Taylor's response to my rebuttal, and my rebuttal to his response, here: